Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $36.9500 (2.21%) ($36.0500 - $37.1500) on Tue. Aug. 21, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.2% (three month average) | RSI | 49 | Latest Price | $36.9500(2.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.9% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.6% in a week (0% probabilities). VXX(-15%) VIXM(-14%) TLT(-14%) UUP(-12%) IFRA(-6%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.6% (StdDev 3.2%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
1 - 5 Day Possible Target | $31.02(-16.05%) | Resistance Level | $37.12 | 5 Day Moving Average | $35.99(2.67%) | 10 Day Moving Average | $36.84(0.3%) | 20 Day Moving Average | $37.12(-0.46%) | To recent high | -28.2% | To recent low | 5.4% | Market Cap | $2.746b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |